Source Natural Foods & Herbal Supplements Share Price

  • 227.954.45 (1.99%)
  • Volume: 62,634
BSE
  • Closed
  • Last Updated On: 29 Aug, 2024, 03:16 PM IST
Loading...

Source Natural Foods & ...

  • 227.954.45 (1.99%)
  • Volume: 62,634
Advertisment

Source Natural share price insights

View All
  • Company's annual revenue growth of 37.89% outperformed its 3 year CAGR of 2.65%. (Source: Standalone Financials)

  • Stock gave a 3 year return of 52.72% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 10.54% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

  • Stock generated 52.72% return as compared to Nifty Pharma which gave investors 64.81% return over 3 year time period. (as of last trading session)

  • Source Natural Foods & Herbal Supplements Ltd. share price moved up by 1.99% from its previous close of Rs 223.50. Source Natural Foods & Herbal Supplements Ltd. stock last traded price is 227.95

    Share PriceValue
    Today/Current/Last-227.95
    Previous Day-223.50

InsightsSource Natural

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    77.68
    EPS - TTM
    (₹)
    2.93
    MCap
    (₹ Cr.)
    141.61
    Sectoral MCap Rank
    124
    PB Ratio
    (x)
    7.40
    Div Yield
    (%)
    0.00
    Face Value
    (₹)
    10.00
    Beta

    Beta

    1 Month0.22
    3 Months0.29
    6 Months0.16
    1 Year0.18
    3 Years0.18

    0.22
    VWAP
    (₹)
    221.15
    52W H/L
    (₹)
    227.95 / 74.50

    Source Natural Share Price Returns

    1 Day1.99%
    1 Week10.33%
    1 Month24.67%
    3 Months168.49%
    1 Year158.15%
    3 Years55.76%
    5 Years258.98%

    ET Stock ScreenersTop Score Companies

    Check whether Source Natural belongs to analysts' top-rated companies list?

    View Stock Screeners

    Source Natural Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Source Natural Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Source Natural Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 37.89% outperformed its 3 year CAGR of 2.65%. (Source: Standalone Financials)
      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 10.54% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income8.176.838.006.895.59
      Total Income Growth (%)19.62-14.6016.0423.36-18.40
      Total Expenses7.525.656.506.595.18
      Total Expenses Growth (%)33.08-13.09-1.2927.13-3.08
      EBIT0.651.181.490.300.40
      EBIT Growth (%)-45.06-21.17395.15-25.16-73.12
      Profit after Tax (PAT)0.420.320.960.180.27
      PAT Growth (%)30.29-66.56425.64-31.53-75.85
      EBIT Margin (%)7.9117.2218.664.377.21
      Net Profit Margin (%)5.144.7212.052.664.79
      Basic EPS (₹)0.650.501.500.280.42
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue27.3019.8022.0225.2213.62
      Total Revenue Growth (%)37.89-10.07-12.7085.236.27
      Total Expenses24.0717.0618.3421.1711.77
      Total Expenses Growth (%)41.08-6.93-13.4079.920.10
      Profit after Tax (PAT)1.742.122.433.371.64
      PAT Growth (%)-18.12-12.80-27.90105.7659.76
      Operating Profit Margin (%)12.5315.0117.8116.6814.79
      Net Profit Margin (%)6.3610.7211.3013.5612.06
      Basic EPS (₹)2.703.303.785.242.55

      All figures in Rs Cr, unless mentioned otherwise

      No reported Profit & Loss Statement are available.

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets23.6521.6919.3217.2213.14
      Total Assets Growth (%)9.0412.2712.2031.0521.67
      Total Liabilities4.203.973.734.063.35
      Total Liabilities Growth (%)5.796.43-8.1321.1966.67
      Total Equity19.4517.7215.6013.169.79
      Total Equity Growth (%)9.7613.5918.5434.4211.38
      Current Ratio (x)4.984.913.763.013.00
      Total Debt to Equity (x)0.000.000.000.070.11
      Contingent Liabilities0.00----

      All figures in Rs Cr, unless mentioned otherwise

      No reported Balance Sheet are available.

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities2.372.51-4.42-0.36
      Net Cash used in Investing Activities0.620.06--2.05-0.71
      Net Cash flow from Financing Activities-0.04-0.53-0.320.32
      Net Cash Flow2.952.04-2.69-0.74
      Closing Cash & Cash Equivalent5.862.91-2.710.01
      Closing Cash & Cash Equivalent Growth (%)101.177.690.000.00-98.25
      Total Debt/ CFO (x)0.000.01-0.21-3.07

      All figures in Rs Cr, unless mentioned otherwise

      No reported Cash Flow Statement are available.

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)8.9211.9715.5925.6316.75
      Return on Capital Employed (%)17.0816.2623.7930.6519.65
      Return on Assets (%)7.349.7712.5819.5812.48
      Interest Coverage Ratio (x)23.0714.4627.8440.0012.28
      Asset Turnover Ratio (x)1.200.961.18144.45103.45
      Price to Earnings (x)32.6827.0325.1928.2528.41
      Price to Book (x)2.923.233.927.244.75
      EV/EBITDA (x)11.4015.9614.1920.6920.29
      EBITDA Margin (%)16.3517.2019.7418.1617.27

      No reported Financial Ratios are available.

    Financial InsightsSource Natural

    • Income (P&L)
      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 37.89% outperformed its 3 year CAGR of 2.65%. (Source: Standalone Financials)

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 10.54% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Source Natural Peer Comparison

    • Source Natural Stock Performance

    • Ratio Performance

    • Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 52.72% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)
      • Stock Returns vs Nifty Pharma

        Stock generated 52.72% return as compared to Nifty Pharma which gave investors 64.81% return over 3 year time period. (as of last trading session)
      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 52.72% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)
      • Stock Returns vs Nifty Pharma

        Stock generated 52.72% return as compared to Nifty Pharma which gave investors 64.81% return over 3 year time period. (as of last trading session)

      Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Source Natural77.687.548.9217.087.342.6512.536.362.704.980.000.00
      MadhuveerCom181,502.7110.927.437.915.83266.2962.0248.172.469.550.217.25
      Aayush Food & Herbs197.0529.6411.6311.9711.39-82.0098.2894.831.768.010.000.00
      S S Organic-481.00-6.790.00-41.74-5.50-8.60-31.06-8.77-1.090.72-2.84-4.39
      Parnax Lab13.181.8913.4216.265.0927.739.215.108.380.920.994.48
      Add More
      Annual Ratios (%)

      Choose from Peers

      • Samrat Pharma
      • Mercury Laboratories
      • Bharat Immunological
      • Auro Labs
      • Everest Org

      Choose from Stocks

      Peers InsightsSource Natural

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 52.72% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)

      • Stock Returns vs Nifty Pharma

        Stock generated 52.72% return as compared to Nifty Pharma which gave investors 64.81% return over 3 year time period. (as of last trading session)

      Do you find these insights useful?

      • hate it

      • meh

      • love it

      Source Natural Shareholding Pattern

      • QOQ Change

      • Total Shareholdings

      • Loading...
        Showing Source Natural Shareholding as on 30 Jun 2024
        Category30 Jun 202431 Mar 202431 Dec 202330 Sep 2023
        Promoters74.3774.3774.3774.37
        Pledge0.000.000.000.00
        FII0.000.000.000.00
        DII0.000.000.000.00
        Mutual Funds0.000.000.000.00
        Others25.6225.6225.6225.62
      • Showing Shareholding as on 30 Jun 2024
        CategoryNo. of SharesPercentage% Change QoQ
        Promoters47,86,89174.37 %0.00
        Pledge00.00 %0.00
        Others16,50,04025.62 %0.00

      MF Ownership

      MF Ownership details are not available.

      Corporate Actions

      • Source Natural Board Meeting/AGM

      • Source Natural Dividends

      • Others
      • Meeting DateAnnounced onPurposeDetails
        Aug 14, 2024Aug 12, 2024Board MeetingQuarterly Results
        Jun 26, 2024Jun 18, 2024Board MeetingOthers
        May 24, 2024May 17, 2024Board MeetingAudited Results
        Feb 14, 2024Feb 05, 2024Board MeetingQuarterly Results
        Nov 09, 2023Nov 02, 2023Board MeetingQuarterly Results
      • Dividend announcements are not available.

      • No other corporate actions details are available.

      About Source Natural

      Source Natural Foods & Herbal Supplements Ltd., incorporated in the year 1995, is a Small Cap company (having a market cap of Rs 146.73 Crore) operating in Pharmaceuticals sector. Source Natural Foods & Herbal Supplements Ltd. key Products/Revenue Segments include Pharmaceuticals and Sale of services for the year ending 31-Mar-2023. Show More

      • Executives

      • Auditors

      • NN

        Narayanan Narasimhan

        Chairman & Non-Exe.Director
        NA

        N Arvind Varchaswi

        Managing Director
        TK

        Tejagna Kashmira Katpitia

        Executive Director
        B

        Bharathy

        Independent Director
        Show More
      • Srinaga & Giridharan

      FAQs about Source Natural share

      • 1. What's Source Natural share price today and what are Source Natural share returns ?
        As on 29 Aug, 2024, 03:16 PM IST Source Natural share price was up by 1.99% basis the previous closing price of Rs 219.15. Source Natural share price was Rs 227.95. Return Performance of Source Natural Shares:
        • 1 Week: Source Natural share price moved up by 10.33%
        • 3 Month: Source Natural share price moved up by 168.49%
        • 6 Month: Source Natural share price moved up by 136.91%
      • 2. What is Source Natural's 52 week high / low?
        Source Natural share price saw a 52 week high of Rs 227.95 and 52 week low of Rs 74.50.
      • 3. Who's the owner of Source Natural?
          • Promoter holding has not changed in last 9 months and holds 74.37 stake as on 30 Jun 2024
          • Other investor holding has not changed in last 9 months and holds 25.62 stake as on 30 Jun 2024
      • 4. What are the returns for Source Natural share?
        Return Performance of Source Natural Shares:
        • 1 Week: Source Natural share price moved up by 10.33%
        • 3 Month: Source Natural share price moved up by 168.49%
        • 6 Month: Source Natural share price moved up by 136.91%
      • 5. What is the PE & PB ratio of Source Natural?
        The PE ratio of Source Natural stands at 76.17, while the PB ratio is 7.4.
      • 6. What's the market capitalization of Source Natural?
        Within the Pharmaceuticals sector, Source Natural stock has a market cap rank of 124. Source Natural has a market cap of Rs 141.61 Cr.
      • 7. Who's the chairman of Source Natural?
        Narayanan Narasimhan is the Chairman & Non-Exe.Director of Source Natural
      • 8. What is the CAGR of Source Natural?
        The CAGR of Source Natural is 2.35.
      • 9. What are the Source Natural quarterly results?
        On Standalone basis, Source Natural reported a total income and profit of Rs 8.17 Cr and Rs 0.42 respectively for quarter ending resultQuarterlyResult.list[0].yearEnding. Total Income and profit for the year ending 2024-03-31 was Rs 27.30 Cr and Rs 1.74 Cr.
      • 10. How can I quickly analyze Source Natural stock?
        Key Metrics for Source Natural are:
        • PE Ratio of Source Natural is 77.68
        • Price/Sales ratio of Source Natural is 2.08
        • Price to Book ratio of Source Natural is 7.40
      • 11. Who are peers to compare Source Natural share price?
        Top 10 Peers for Source Natural are Mercury Laboratories Ltd., Parnax Lab Ltd., Auro Laboratories Ltd., Madhuveer Com 18 Network Ltd., Everest Organics Ltd., Samrat Pharmachem Ltd., Aayush Wellness Ltd., Biofil Chemicals & Pharmaceuticals Ltd., Bharat Immunological & Biologicals Corporation Ltd. and Oxygenta Pharmaceutical Ltd.

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.

      The Economic Times